MCTA vs NPCE
Comparison between Charming Medical Ltd - Class A (MCTA, Company) and NeuroPace Inc (NPCE, Company).
Both MCTA and NPCE are from the Healthcare sector.
MCTA vs NPCE - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
MCTA
$497M
NPCE
$494M
Max Drawdown
Winner
MCTA
25.58%
NPCE
95.13%
Sharpe Ratio
Winner
MCTA
2.29
NPCE
0.96
5Y Beta
Winner
MCTA
0.42
NPCE
1.18
Industry
MCTA
Medical Care Facilities
NPCE
Medical Devices
P/E Ratio
MCTA
414.66
Winner
NPCE
-22.59
PEG Ratio
MCTA
7.66
NPCE
N/A
Debt to Equity
MCTA
2356.96%
Winner
NPCE
408.34%
Free Cash Flow Yield
Winner
MCTA
0.03%
NPCE
-1.99%
P/S Ratio
MCTA
92.98
Winner
NPCE
4.99
P/B Ratio
MCTA
10240.24
Winner
NPCE
36.47
MCTA vs NPCE - Historical Returns
Returns include dividend reinvestment.
1M
Winner
MCTA
+0.00%
NPCE
-8.69%
3M
Winner
MCTA
+0.00%
NPCE
-11.85%
6M
Winner
MCTA
+0.00%
NPCE
-11.37%
1Y
MCTA
N/A
NPCE
+63.29%
5Y(CAGR)
MCTA
N/A
NPCE
-8.85%
Max(CAGR)
Winner
MCTA
+566.67%
NPCE
-9.46%
MCTA vs NPCE - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | MCTA | NPCE |
|---|---|---|
| 2026 | +0.00% | -2.37% |
| 2025 | +319.36% | +33.33% |
| 2024 | N/A | +14.42% |
| 2023 | N/A | +615.97% |
| 2022 | N/A | -85.70% |
| 2021 | N/A | -59.62% |
MCTA vs NPCE Drawdown Comparison
The maximum drawdown for MCTA was -25.58%, occurring on Nov 6, 2025. Recovery took 8 trading sessions.
The maximum drawdown for NPCE was -95.13%, occurring on Dec 28, 2022. This drawdown has not yet recovered.
The current NPCE drawdown is -44.11%.
| Rank | MCTA | NPCE |
|---|---|---|
| #1 | -25.58% Oct 30, 2025 - Nov 11, 2025 | -95.13% Apr 27, 2021 - Dec 28, 2022 |
| #2 | -11.43% Oct 21, 2025 - Oct 24, 2025 | N/A |
Correlation
Correlation between MCTA and NPCE is 0.85 which considered as a strong positive correlation - the stocks tend to move together.
0.85
-101
Select Stocks to Compare
Popular: MCTA vs SPYNPCE vs SPY
More Comparisons
Compare with similar stocks